Ramalingam, Suresh S.
Emory University School of Medicine,
United States
2025 Rank: 19114
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 835 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19114 | 20215 |
| Total Cites | 77375 | 85182 |
| H-index | 112 | 118 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 17 |
| Number of Single+First Authored Papers | 84 | 84 |
| Total Cites to Single+First Authored Papers | 5776 | 6196 |
| Number of Single+First+Last Authored Papers | 194 | 194 |
| Total Cites to Single+First+Last Authored Papers | 13631 | 14440 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 58329 | 62631 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.36 |
| Self-Citation Percentage |
9.17%
|
|
Ramalingam, Suresh S.
Emory University,
United States
2024 Rank: 20346
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 921 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20346 | 22208 |
| Total Cites | 65598 | 72418 |
| H-index | 106 | 110 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 80 | 80 |
| Total Cites to Single+First Authored Papers | 5171 | 5548 |
| Number of Single+First+Last Authored Papers | 180 | 180 |
| Total Cites to Single+First+Last Authored Papers | 11937 | 12642 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 49605 | 53437 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.36 |
| Self-Citation Percentage |
9.42%
|
|
Ramalingam, Suresh S.
Emory University,
United States
2023 Rank: 23413
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1069 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23413 | 26196 |
| Total Cites | 52865 | 58392 |
| H-index | 94 | 95 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 79 | 79 |
| Total Cites to Single+First Authored Papers | 4588 | 4918 |
| Number of Single+First+Last Authored Papers | 174 | 174 |
| Total Cites to Single+First+Last Authored Papers | 10192 | 10785 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 40310 | 43566 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.34 |
| Self-Citation Percentage |
9.47%
|
|
Ramalingam, Suresh S.
Emory University,
United States
2022 Rank: 26312
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1207 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26312 | 29450 |
| Total Cites | 40097 | 44494 |
| H-index | 86 | 88 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 77 | 77 |
| Total Cites to Single+First Authored Papers | 3885 | 4172 |
| Number of Single+First+Last Authored Papers | 169 | 169 |
| Total Cites to Single+First+Last Authored Papers | 8287 | 8795 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 31048 | 33702 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.32 |
| Self-Citation Percentage |
9.88%
|
|
Ramalingam, Suresh S.
Emory University,
United States
2021 Rank: 105468
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4153 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105468 | 116347 |
| Total Cites | 6324 | 6796 |
| H-index | 44 | 47 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 2610 | 2758 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 3479 | 3674 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5794 | 6126 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
6.95%
|
|
Ramalingam, Suresh S.
Emory University,
United States
2020 Rank: 95615
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3969 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95615 | 108928 |
| Total Cites | 5789 | 6213 |
| H-index | 43 | 44 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 2433 | 2577 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 3213 | 3383 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5287 | 5587 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
6.82%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.